Thrombocytosis on Adult Patient with SARS-Cov-2 in Africa
Journal: Haematology International Journal (HIJ) (Vol.4, No. 2)Publication Date: 2020-07-03
Authors : Ngolet LO Kie FU Moyikoua R; Ngokaba TO;
Page : 1-4
Keywords : Novel Coronavirus; SARS-Cov-2 pneumonia;
Abstract
The 2019-2020 pandemic caused by a novel coronavirus, SARS-Cov-2 or COVID-19 is ongoing. The outbreak of a respiratory illness caused by COVID-19 was first identified in Wuhan, Hubei Province, China and declared by the local authorities in December 2019. Since the beginning of the pandemic, Governments and health authorities across the world are striving to limit the widespread of the virus. The African continent registered its first cases about two months ago, and then readily implemented massive preventive measures such as lockdown, confinement and curfew. Like others, African Scientists are learning from and sharing their experiences about the disease. The aim of this article is to present a case of a COVID-19-related moderate pneumonia with unusual laboratory findings. This study has been approved by the local bioethics committee.
Other Latest Articles
- Transfusion Transmitted Infections in Patients with Haemophilia, a Study from Western Rajasthan, India
- Who is at Risk? Lessons Learned
- Haemovigilance Fact and Fiction
- Evaluation of Soluble Intercellular Adhesion Molecule-1 and Soluble P Selection in Sickle Cell Disease
- COVID19 War, Triangle with Inflammation and Infection
Last modified: 2022-09-12 18:14:20